HIF Prolyl Hydroxylase Inhibitor
CAS: 385786-48-1
Ref. 3D-KQA78648
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
The HIF prolyl hydroxylase inhibitor is a monoclonal antibody that targets the activity of a protein involved in the regulation of oxygen levels. This protein, HIF prolyl hydroxylase, is responsible for the production of two proteins: erythropoietin and vascular endothelial growth factor (VEGF). The HIF prolyl hydroxylase inhibitor drug results in a cascade of events that leads to an increase in oxygen levels in tissues, preventing hypoxia-induced neuronal death. The HIF prolyl hydroxylase inhibitor has also shown promising results as a treatment for inflammatory bowel disease, which is characterized by increased intestinal permeability. It has been shown to inhibit viral replication and reduce the severity of symptoms related to bowel diseases.
